OFFICIAL PUBLICATION OF

pdl.com.au

by its subsidiary APPco

New Hepatitis C treatment TGA registered

Megan Haggan 06/09/2016

Hepatitis Virus - 3D Render

The TGA has registered a new treatment regimen for the treatment of chronic Hepatitis C.MSD announced that Zepatier (elbasvir/grazoprevir) with or without ribavirin has been registered by the TGA for the treatment of chronic hepatitis C virus genotype 1 and 4 infection in adults.The regimen is a once-daily tablet taken for 12 weeks, and is

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

Funding secured for non-8CPA programs

Medschecks and Diabetes MedsCheck are included and funded under the 8CPA. The programs under the 8CPA will be undergoing a…

Anthony Tassone

Eli Lilly clarifies Mounjaro availability

One would think they could have made a commercial decision eith a needle maker to supply requisite number of needles…

Erin Threlfall

Funding secured for non-8CPA programs

This is a big step forward in securing the sustainability and viability of HMRs and RMMRs. Remember there is an…

Debbie Rigby

Funding secured for non-8CPA programs

So well done to the PSA for securing this funding. So important that these very valuable program finally gets looked…

Bente Hart